HPV Infection and associated disease among HIV positive individuals. Admire Chikandiwa. Wits RHI

Similar documents
Update of the role of Human Papillomavirus in Head and Neck Cancer

Human Papillomavirus

HPV-Associated Disease and Prevention

HIV-infected men and women. Joel Palefsky, M.D. University of California, San Francisco

HPV Epidemiology and Natural History

Towards the elimination of HPV

HPV FREE IDAHO. Fundamentals of HPV Bill Atkinson, MD MPH

Human Papillomavirus (HPV) in Patients with HIV.

Bottoms UP HIV and Anal Cancer from Screening to Prevention

Jean Anderson, MD Catherine Sewell, MD, MPH

INTRODUCTION HUMAN PAPILLOMAVIRUS

Oral HPV infection and the changing epidemiology in head and neck cancer

An update on the Human Papillomavirus Vaccines. I have no financial conflicts of interest. Case 1. Objectives 10/26/2016

The HPV Vaccination Programme Early intervention in cancer prevention Northern Ireland

Carolyn Johnston, MD Clinical Professor University of Michigan and St. Joseph Mercy Hospital Gynecologic Oncology Sept 2014

Update on HPV Testing. Robert Schlaberg, M.D., Dr. med., M.P.H. Assistant Professor, University of Utah Medical Director, ARUP Laboratories

Anal Cancer and HPV Related Tumor Prevention

Pathology of the Cervix

Update on Anal HPV. Medical Management of AIDS. December 9, Joel Palefsky Department of Medicine University of California, San Francisco

Guidance Document on HPV Vaccination in Public HIV and STI Clinics

HPV & RELATED DISEASES

Goals. In the News. Primary HPV Screening 3/9/2015. Your PAP and HPV Update Primary HPV Testing- Screening Intervals- HPV Vaccine Updates-

THE PERFORMANCE OF CEPHEID XPERT HPV

Preventive Vaccines against HPV. Paris, 2 April 2015 Yvonne Deleré, MD (former) Immunization Unit, Robert Koch Institute, Berlin

Focus. International #52. HPV infection in High-risk HPV and cervical cancer. HPV: Clinical aspects. Natural history of HPV infection

HPV vaccination Where are we now? Where are we going? Margaret Stanley Department of Pathology Cambridge

Should Anal Pap Smears Be a Standard of Care in HIV Management?

SCCPS Scientific Committee Position Paper on HPV Vaccination

Trends in HPV-Associated Cancers United States,

The Global Burden of HPV Related Cancers and Their Prevention

Objectives. HPV Classification. The Connection Between Human Papillomavirus and Oropharyngeal Cancer 6/19/2012

Human papillomavirus and vaccination for cervical cancer

SENTINEL SURVEILLANCE OF HUMAN PAPILLOMAVIRUS GENOTYPES AMONG YOUNG WOMEN ATTENDING PUBLIC HEALTHCARE FACILITIES IN SOUTH AFRICA, 2017

- ii - Rights c

How do we compare? IP724/BMTRY Introduction to Global and Public Health. Feb 21, 2012 Basic Science Rm Sharon Bond, PhD, CNM

IS39 CP6108 [1]

Cervical Cancer Screening. David Quinlan December 2013

Global HPV Disease Burden : Rationale for Vaccine

EXPOSING DANGERS OF HUMAN PAPILLOMAVIRUS IN BOTH MEN AND WOMEN

What are the implications of HPV in the biology of Head and Neck Cancer?

Focus. A case. I have no conflicts of interest. HPV Vaccination: Science and Practice. Collaborative effort with Karen Smith-McCune, MD, PhD 2/19/2010

HPV AND CERVICAL CANCER

Cervical Dysplasia and HPV

HPV Transmission. Rachel Winer, PhD, MPH Department of Epidemiology University of Washington

ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals

Following microtrauma, HPV s bind to the basement membrane, infect basal cells, and replicate in suprabasal cells

PREINVASIVE DISEASE OF THE LOWER GENITAL TRACT DR AI LING TAN GYNAECOLOGICAL ONCOLOGIST ASCOT CLINIC,ADHB

The HPV Immunisation Programme in NZ. Chris Millar Senior Advisor Immunisation Ministry of Health

Clinical Care of Gynecological Problems in HIV. Howard P Manyonga SA HIV Clinicians Society Conference 26 September 2014

Real-life challenges in implementing public strategies for HPV vaccination in developing countries, and strategies to increase immunization coverage

Disclosures. New ACIP Recommendations for HPV Vaccination. Human Papillomaviruses. Objectives

Malignancies in HIV. Prof. S. DE WIT Saint-Pierre University Hospital Brussels, Belgium

HPV-related papillomatous-condylomatous lesions in female anogenital area

PRODUCT INFORMATION GARDASIL 9. [Human Papillomavirus 9-valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) vaccine, Recombinant]

OPPORTUNISTIC HPV VACCINATION: AN EXPANDED VISION

HPV is the most common sexually transmitted infection in the world.

Human Papillomavirus. Kathryn Thiessen, ARNP, ACRN The Kansas AIDS Education and Training Center The University of Kansas School of Medicine Wichita

Cervical Cancer Screening Guidelines Update

HUMAN PAPILLOMAVIRUS VACCINES AND CERVICAL CANCER

Cytyc Corporation - Case Presentation Archive - June 2003

O RIGINAL P APER. Extending Quadrivalent Human Papilloma Virus (HPV) Vaccination To Males What Is The Current Evidence?

SESSION J4. What's Next? Managing Abnormal PAPs in 2014

Cancer in the LGBTQ Community. Katie Imborek, MD Clinical Assistant Professor University of Iowa Department of Family Medicine

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Human Papillomavirus (HPV): Vaccine-Preventable Disease

HPV infections and potential outcomes

The HPV Cancer Epidemic: Why We Must Vaccinate Our Boys Acadiana Potpourri Lafayette, Louisiana August 19, 2017

HPV the silent killer, Prevention and diagnosis

Woo Dae Kang, Ho Sun Choi, Seok Mo Kim

Professor Margaret Stanley

Alexandra Lydia Hernandez. A dissertation submitted in partial satisfaction of the. requirements for the degree of. Doctor of Philosophy.

F.C. Shakhtatinskaya, L.S. Namazova-Baranova, V.K. Tatochenko, D.A. Novikova, T.E. Tkachenko

Incidence, Persistence, and Recurrence of Anogenital α- Mucosal HPV Infections (HPV 6, 11, 16, 18, 31, 33, 45, 52 and 58)

Chapter 2: Disease Burden and Cervical Screening in Ontario

Anna R Giuliano, PhD Center for Infection Research in Cancer Moffitt Cancer Center

Prophylactic HPV Vaccines. Margaret Stanley Department of Pathology Cambridge

HPV Vaccine Ina Park, MD, MS

National Immunisation Conference 25th May 2018

Summary Dose Schedule 2. 9HPV vaccine 3. Primary HPV screening 4. Male vaccination 5. Update on Australia 6. Natural History 7.

Concern for recurrence Stable virus especially in freeze dried form High infectivity in humans Vaccine supplies are limited No specific antiviral

Population-level effectiveness & cost-effectiveness of the 9-valent HPV vaccine

Making Sense of Cervical Cancer Screening

An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two

Promoting Cervical Screening Information for Health Professionals. Cervical Cancer

The Role of Epidemiologic Studies in Establishing HPV as a Cause of Cancer. April 2, 2008 Margaret M. Madeleine, PhD. Outline

HUMAN PAPILLOMAVIRUS

Prevalence of human papillomavirus in men who have sex with men in the era of an effective vaccine; a call to act

Eradicating Mortality from Cervical Cancer

MEDICAL POLICY EFFECTIVE DATE: 12/20/12 REVISED DATE: 11/21/13, 10/16/14 SUBJECT: HIGH RESOLUTION ANOSCOPY

HPV and Lower Genital Tract Disease. Simon Herrington University of Edinburgh, UK Royal Infirmary of Edinburgh, UK

Human Papillomavirus Infection

Prevalence Of Precancerous Lesions Of The Uterine Cervix

Draft Health Technology Assessment (HTA) of HPV vaccination of boys Health Information and Quality Authority

Opinion: Cervical cancer a vaccine preventable disease

Background HPV causes virtually all cervical cancers HPV-16, Integration of viral oncogenes E6 and E7 Relationship between HPV and cervical cancer wou

Vaccine administration. Dr Brenda Corcoran National Immunisation Office

HPV and Genital Dermatology. Jean Anderson MD Director, Johns Hopkins HIV Women s Health Program June 2017

Learning Objectives. What is HPV? Incidence in the U.S. 5/22/2013. Human papillomavirus Infections

Human Papillomaviruses: Biology and Laboratory Testing

Transcription:

HPV Infection and associated disease among HIV positive individuals Admire Chikandiwa Wits RHI

Outline of presentation Introduction Burden of HPV associated diseases The role of HIV and its interaction in HPV associated diseases Current prevention and treatment for HPV associated diseases Conclusion and Acknowledgements

Introduction Human papillomavirus (HPV) classified a Group 1 by IARC in 1995. Causative role in cervical cancer described in 1999 Extensive data on the burden of HPV associated diseases among women including: anogenital warts, cancers of the cervix, vulva, vagina, anus, head & neck The recognition that HPV infection also causes a significant and growing burden of disease in men has led to increasing interest in HPV infection and disease in both heterosexual men and men who have sex with men (MSM) New evidence suggests that: men are also have high a prevalence of HPV infection Additionally they are frequently are infected with multiple HPV types IARC, 1995 Walboomers et al., Journal of Pathology, 1999

Human Papillomaviruses Viral structure: circular double-stranded DNA genome 2 capsid proteins (L1, L2) 3 oncogenes (E5, E6 and E7) modulate the transformation process Subtype classification based on L1: 100 genotypes: 40 genital, >13 linked to cancer High-risk types (HPV 16, 18, etc) Cervical, anal, vulvar, vaginal, penile cancers and their precursor lesions Low-risk types (HPV 6, 11, etc) Anogenital warts (AGWs) Cancer Facts, ACS, 2003

Incidence cancer attributable to HPV in 2008 Cancer Site Number of cases Number attributable to HPV PAF (%) Cervix uteri 530 000 530 000 100 Vulva 27 000 12 000 43 Anus 27 000 24 000 88 Penis 22 000 11 000 50 Vagina 13 000 9 000 70 Oropharnyx 85 000 22 000 26 Total 700 000 610 000 86 Forman et al., Vaccine, 2012

Incidence of AGWs Global estimates from a systematic review of 37 studies: 160 to 289 per 100 000 AGWs are benign but are responsible for a huge burden of morbidity and costs due to: Frequent recurrence Often multiple visits to the health care facilities for treatment Pyschosocial distress Among HIV positive individuals AGWs are florid and even have a prolonged clinical course. Patel et al., BMC Infectious disease, 2013

HIV, HPV and associated disease Impaired immune response increases susceptibility to acquisition of HPV infection reactivation of latent HPV infection Impaired clearance of oncogenic viral infections Chronic inflammation promotes carcinogenesis by generation of genotoxic reactive oxygen and nitrogen species procarcinogenic cytokines and growth factors HIV +ve individuals are more likely to have prevalent and persistent HPV infection to progress in pre-cancerous lesions or cancer Phanuphak et al., J Acquir Immune Defic Syndr, 2014 Vessely et al., Annu Rev Immunol, 2011 Schottenfield et al., CA Cancer J Clin,2006 Dubrow et al., Curr Opin Oncol,2012

Prevalence (%) Prevalence of cervical HPV DNA by age and HIV status among 349 women in BF HIV+ HIV- HIV prevalence =16% Didelot-Rousseau et al., Br J Cancer, 2006

Prevalence of HR-HPV among 1371 HIV+ and 8050 HIV- women in Cape Town HIV prevalence =14.6% McDonald AC et al., Frontiers Oncol 2014

High risk of HPV Cervical Cancer among HIV positive individuals Linkage studies of ART and Cancer registries show: a 2- to 22-fold increase in Ca CX in HIV+ compared to HIV women. Women in Southern Africa are at markedly Region HR (95% CI) HR (95% CI) at 2yrs after ART initiation at 5yrs after ART initiation higher risk than women in HICs. Europe 1 1 North America 1 1 Among Southern African women, incidence Latin America 2.1 (0.8-5.0) 2.2 (1.2-4.2) Southern Africa 8.9 (6.0-13.3) 12.4 (7.8-20.0) rates do not decline with time on ART Rhoner et al., CROI, 2016

Cancers among HIV positive individuals in SA Sengayi et al., CROI, 2016

Biological interaction between HPV and HIV HIV infection modifies significantly the distribution of HPV types in cervical cancer Low CD4+ counts are the strongest independent predictor for HPV infection and AGWs HPV infection is independently associated with an increased risk of HIV acquisition It is hypothesized that postulated new infections elicit a local immune response to clear the HPV infection This response recruits immune cells which may be vulnerable to infection with HIV Naulcer et al., Journal of General Virology, 2011 Sahasrabuddhe et al., Br J Cancer, 2007 De Sanjose et al., Lancet Oncol, 2010 Smith et al., J Infect Dis, 2010 Smith-McCune., Plos 1, 2010

Collins et al., Br J Obstet Gynaecol, 2002

Prevalence HIV +ve adolescents are 3 times more likely to have cytological abnormalities compared to their HIV -ve counterparts HPV in Adolescents 35 30 25 HPV infection and cervical disease among HIV positive adolescent in Cape Town 31 21 29 A study done in Cape Town on 83 HIV +ve young women of mean age (sd) 19.9(1.1) has confirmed this 20 15 10 5 Alder et al., Infectious Dis Obstet Gyneco, 2014 Nachman et al., Archiv Pediatrc Adolesc Med, 2009 0 Any HPV Any HR HPV Cytological abnormalities

HPV infection and the anal canal 1983: Areas of epithelial transformation susceptible to HPV infection share similarities with transformation zone (TZ) of cervix This epithelium undergoes metaplasia Almost all anal carcinomas arise in the TZ 2007 IARC concludes sufficient evidence for carcinogenicity of HPV in penis, anus, oral cavity, oropharynx, tonsils Yang et al., Mod Pathol, 2015 Darragah et al., J Low Genit Tract Dis, 2012

Partridge, 2006 Anal cancer incidence is rising

HPV infection in the head & neck Preference for the oropharynx not clearly understood could be due to the transitional epithelium Tonsillar epithelium is histologically similar to the cervical and anal epithelia Invagination of the mucosal surface. may favor virus capture and maintenance by promoting access to and infection of basal cells Detection rate of HPV is much higher in oral rinse than with swabs Frisch et al., Journal of the National Cancer Institute, 2000 Chu et al., Oncology, 2013 Read et al., Plos 1, 2012

HPV infection in the head & neck Preference for the oropharynx not clearly understood could be due to the transitional epithelium Tonsillar epithelium is histologically similar to the cervical and anal epithelia Invagination of the mucosal surface. may favor virus capture and maintenance by promoting access to and infection of basal cells Detection rate of HPV is much higher in oral rinse than with swabs Frisch et al., Journal of the National Cancer Institute, 2000 Chu et al., Oncology, 2013 Read et al., Plos 1, 2012

Rising oropharyngeal cancer especially in men Maura et al., JCO, 2015

Associations between number of oral sex partners and oral HPV prevalence Maura et al., JCO. 2015

Effect of ART on HPV associated disease ART induced immune reconstitution has reduced incidence of AIDS related cancers e.g. KS and NHL Immune reconstitution leads to clearance of oncogenic viral infections ART improves life expectancy lengthening exposure time to HR-HPV allows for accumulation of genetic changes that increase the likelihood of cancer Palefsky., Adv Dent Res. 2006 Shiels et al., J Natl Cancer Inst, 2011

ART and HPV associated cancer Effect on HPV associated cancers is be unclear Cervical dysplasia and Cancer: Some studies have reported a protective effect on prevalence and progression of CIN2+ lesions but this has not been confirmed in by other studies Anal cancer: incidence has increased Head & Neck cancer: incidence has increased. Firnhaber et al., JIAS, 2012 Ezechi et al., Plos 1, 2014 Zhang et al., APJCP, 2012 De Vuyst et al., Br J Cancer, 2012 Piketty et al., AIDS, 2013 Beachler et al., Curr Opin Oncol, 2013

Treatment and prevention options

Treatment for anogenital warts and neoplastic lesions Topical agents TCA, podophylin, podophylotoxin, 5-FU Ablative therapies CO2 laser Surgical excision Immune modulators Imiquimod, intra-lesional interferon

Screening Anal intraepithelial neoplasia (AIN), like its cervical counterpart, CIN, is a potential precursor lesion of squamous cell carcinoma of the anus AIN screening analogous to pap smear programs for CIN have been recommended in high-risk populations to reduce the incidence of anal carcinoma in certain high income countries Cytological analysis followed by high resolution anoscopy (HRA) in case of anal dysplasia Despite these guidelines challenges still remain: HRA is expensive and unavailable in low & middle income countries Utility of screening is questionable given the emerging evidence that some of AIN regresses spontaneously. Absences of molecular biomarkers to stratify individuals at high risk of progression Machalek et al., Lancet Oncol, 2012

Prevention options: condoms Results from several studies now suggest that increased condom usage is associated with lower rates of HPV DNA detection There is also evidence that using condoms leads to a more rapid regression of both penile and cervical intraepithelial lesions, as well as a more rapid clearance of genital HPV infection in women It is important to note that condoms provide a protective barrier against the transmission of HPV by skin to skin contact; however, individuals can be infected with HPV on areas not protected by a condom

Condom protection is partial Winer et al, N Engl J Med, 2005

Prevention options: male circumcision MC trials in SA and Uganda have shown a reduction in the prevalence of both HR- and LR- HPV types with circumcision in HIV-seronegative men In Rakai, MC was found to reduce both the prevalence and incidence of multiple HR-HPV types in those men who were HIV-seropositive

Prevention options: HPV vaccines Globally 3 vaccines are available estimated to prevent up to 80% of HPV associated cancers Bivalent (Cervarix ), Quadrivalent (Gardasil ) & nonavalent (Gardasil 9) LR 6, 11, and HR 16, 18, 31, 33, 45, 52 and 58 All vaccines have been shown to be safe and immunogenic in HIV positive individuals Quadrivalent protects HIV +ve women against cervical and anogenital disease WHO recommends three-dose schedule (0, 1 2, 6 months) for HIV +ve girls (regardless of whether they are on ART) Questions still remains on whether to include boys, men or HIV positive individuals esp in LMICs Denny et al., Vaccine, 2013 Olsson et al., Human Vaccines, 2009

Conclusions There is an increased burden of HPV related diseases among women, men and adolescents The burden is even higher among PLWHA The role of ART in reducing the burden of HPV associated cancers is unclear Condoms and male circumcision prevent HPV infection More data is required on: the utility of screening for AIN in HIV+ men whether boys or HIV + positive men should be vaccinated

Acknowledgements Wits RHI Sinead Delany-Moretlwe Pedro Pisa Michelle Moorhouse Ntombizethu Dumakude